The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Acedoxin     4- [(3S,5R,8R,9S,10S,13R,14S,17R) -3-[(2R,4S...

Synonyms: Cardigin, Digilong, Digitrin, Myodigin, Purpurid, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Coramedan

 

Psychiatry related information on Coramedan

 

High impact information on Coramedan

 

Chemical compound and disease context of Coramedan

 

Biological context of Coramedan

 

Anatomical context of Coramedan

 

Associations of Coramedan with other chemical compounds

 

Gene context of Coramedan

  • In vitro experiments were performed with cytosolic and microsomal fractions of human liver specimens in order to investigate which enzyme forms of sulfotransferase (ST) and UDP-glucurosyltransferase (GT) are involved in the metabolism of digitoxin (dt-3) and/or its cleavage products [25].
  • Hydroxysteroid sulfotransferase and a specific UDP-glucuronosyltransferase are involved in the metabolism of digitoxin in man [25].
  • In rats, cytochrome P450 (P450) IIIA enzymes are an important determinant of digitoxin toxicity [11].
  • Based on this correlation, we correctly predicted that hamsters, which have the highest P450 IIIA activity, are extremely resistant to digitoxin toxicity [11].
  • Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin [11].
 

Analytical, diagnostic and therapeutic context of Coramedan

References

  1. Use of cholestyramine resin in digitoxin toxicity. Pieroni, R.E., Fisher, J.G. JAMA (1981) [Pubmed]
  2. The effect of chronic digitoxin administration on the contractile state of normal and nonfailing hypertrophied myocardium. Williams, J.F., Potter, R.D. J. Clin. Invest. (1975) [Pubmed]
  3. Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform. Wang, J.K., Portbury, S., Thomas, M.B., Barney, S., Ricca, D.J., Morris, D.L., Warner, D.S., Lo, D.C. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  4. Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Srivastava, M., Eidelman, O., Zhang, J., Paweletz, C., Caohuy, H., Yang, Q., Jacobson, K.A., Heldman, E., Huang, W., Jozwik, C., Pollard, B.S., Pollard, H.B. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  5. Effect of physical activity on serum concentrations of digoxin and digitoxin. Grille, W., Welter, U., Johnsen, K., Kolenda, K.D., Löffler, H. Eur. J. Clin. Pharmacol. (1996) [Pubmed]
  6. Digitoxin intoxication with lethal outcome. Krappweis, J., Petereit, G., Justus, J., Altmann, E., Kirch, W. Eur. J. Med. Res. (1996) [Pubmed]
  7. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments. Ochs, H.R., Smith, T.W. J. Clin. Invest. (1977) [Pubmed]
  8. Digitoxin elimination reduced during quinidine therapy. Garty, M., Sood, P., Rollins, D.E. Ann. Intern. Med. (1981) [Pubmed]
  9. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Yang, Q., Huang, W., Jozwik, C., Lin, Y., Glasman, M., Caohuy, H., Srivastava, M., Esposito, D., Gillette, W., Hartley, J., Pollard, H.B. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  10. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Dostanic-Larson, I., Van Huysse, J.W., Lorenz, J.N., Lingrel, J.B. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  11. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin. Eberhart, D.C., Gemzik, B., Halvorson, M.R., Parkinson, A. Mol. Pharmacol. (1991) [Pubmed]
  12. Reductive inactivation of digitoxin by Eubacterium lentum cultures. Chandrasekaran, A., Robertson, L.W., Reuning, R.H. Appl. Environ. Microbiol. (1987) [Pubmed]
  13. Digitoxin therapy partially restores cardiac catecholamine and brain serotonin metabolism in congestive heart failure. Sole, M.J., Benedict, C.R., Versteeg, D.H., de Kloet, E.R. J. Mol. Cell. Cardiol. (1985) [Pubmed]
  14. Concentration of digoxin, methyldigoxin, digitoxin and ouabain in the myocardium of the dog following coronary occulsion. Kuhlmann, J., Kötter, V., von Leitner, E., Arbeiter, G., Schröder, R. Naunyn Schmiedebergs Arch. Pharmacol. (1975) [Pubmed]
  15. 7 beta -hydroxycardenolide glycosides. Szeleczky, Z., Sóti, M., Horváth, G., Albrecht, K. Steroids (1981) [Pubmed]
  16. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. Smith, T.W. J. Am. Coll. Cardiol. (1985) [Pubmed]
  17. Digitoxin in patients with hepatorenal insufficiency after repeated oral administration. Kirch, W., Ohnhaus, E.E., Pabst, J., Storstein, L. Eur. Heart J. (1989) [Pubmed]
  18. Disposition of digitoxin in renal failure. Vöhringer, H.F., Rietbrock, N., Spurny, P., Kuhlmann, J., Hampl, H., Baethke, R. Clin. Pharmacol. Ther. (1976) [Pubmed]
  19. Studies on digitalis. XI. Digitoxin metabolism in patients with impaired renal function. Storstein, L. Clin. Pharmacol. Ther. (1977) [Pubmed]
  20. Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects. Graves, P.E., Fenster, P.E., MacFarland, R.T., Marcus, F.I., Perrier, D. Clin. Pharmacol. Ther. (1984) [Pubmed]
  21. Effect of heparin on digitoxin protein binding. Lohman, J.J., Hooymans, P.M., Koten, M.L., Verhey, M.T., Merkus, F.W. Clin. Pharmacol. Ther. (1985) [Pubmed]
  22. Characterization of the alpha +-like Na+,K+-ATPase which mediates ouabain inhibition of adrenergic induction of N-acetyltransferase (EC 2.3.1.87) activity: studies with isolated pinealocytes. González-García, C., Ceña, V., Klein, D.C. Mol. Pharmacol. (1987) [Pubmed]
  23. Effects of quinidine on pharmacokinetics and pharmacodynamics of digitoxin achieving steady-state conditions. Kuhlmann, J., Dohrmann, M., Marcin, S. Clin. Pharmacol. Ther. (1986) [Pubmed]
  24. Fluoroimmunoassay of digitoxin in serum. Al-Hakiem, M.H., Simon, M., Mahmod, S., Landon, J. Clin. Chem. (1982) [Pubmed]
  25. Hydroxysteroid sulfotransferase and a specific UDP-glucuronosyltransferase are involved in the metabolism of digitoxin in man. Schmoldt, A., Blömer, I., Johannes, A. Naunyn Schmiedebergs Arch. Pharmacol. (1992) [Pubmed]
  26. Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis. Finkelstein, F.O., Goffinet, J.A., Hendler, E.D., Lindenbaum, J. Am. J. Med. (1975) [Pubmed]
  27. Digitoxin kinetics and renal excretion in children. Larsen, A., Storstein, L. Clin. Pharmacol. Ther. (1983) [Pubmed]
 
WikiGenes - Universities